Namrata Setia to Octreotide
This is a "connection" page, showing publications Namrata Setia has written about Octreotide.
Connection Strength
0.061
-
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Nov 01; 31(11).
Score: 0.061